Breast Biopsy System Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

MARKET INTRODUCTION

A breast biopsy involves removal breast tissue sample to test breast cancer or other breast related disorders. Breast biopsy is mainly used to detect breast cancer.

MARKET DYNAMICS

The breast biopsy system market is driving due to prevalence of breast cancer or suspicious lesions. However, high procedure cost and side effects such as bleeding and infection is expected to hamper the growth of the global breast biopsy system market. Moreover, increasing level of awareness is anticipated to drive demand the growth of the market.

MARKET SCOPE

The "Breast Biopsy System Market Analysis to 2031" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of breast biopsy system market with detailed market segmentation by product type, procedure type, technology, end user. The breast biopsy system market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Breast biopsy system market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The breast biopsy system market is segmented based on product type, procedure type, technology, end user. Based on product type, the market is segmented into needle aspiration (FNA) biopsy, core needle biopsy, surgical biopsy, and biopsy markers. Based on guidance technology, the market is segmented into ultrasound-guided, mammography-guided, and magnetic resonance. Based on end user, the market is segmented into, hospitals, ambulatory surgical centers, diagnostic centers, research laboratories, and others.
?
REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Breast Biopsy System market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Breast Biopsy System market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Breast Biopsy System market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely, North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social, and technological factors effecting the Breast Biopsy System market in these regions.

Breast Biopsy System Market Report Analysis

Breast Biopsy System Market

• 
  CAGR (2023 - 2031)

  XX%
• Market Size 2023
  US$ XX Million
• Market Size 2031
  US$ XX Million

Report Coverage

• Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope

• Key future trends
• Detailed PEST/Porter’s Five Forces and SWOT analysis

• Industry landscape and competition analysis & recent developments
• Detailed company profiles

• Global and regional market analysis covering key market trends, major players, regulations, and recent market developments

Key Players

• Biomed Diagnostics, Inc.,
• Bard Peripheral Vascular Inc.
• F. Hoffmann-La Roche Ltd.
• Hologic Inc.
• Leica Biosystems
• OncoCyte Corporation
• Laboratory Corporation of America Holdings (Labcorp)
• Becton, Dickson and Company
• Danaher Corporation

Regional Overview

• North America
• Europe
• Asia-Pacific
• South and Central America
• Middle East and Africa

Market Segmentation

By Product Type

• Needle Aspiration Biopsy
• Core Needle Biopsy
• Surgical Biopsy
• Biopsy Markers

By Guidance Technology

• Ultrasound-Guided
• Mammography-Guided
• Magnetic Resonance

By End User

• Hospitals
• Ambulatory Surgical Centers
• Diagnostic Centers
• Research Laboratories

MARKET PLAYERS

The report covers key developments in the Breast Biopsy System market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Breast Biopsy System market are anticipated to have lucrative growth opportunities in the future with the rising demand for Breast Biopsy System market in the global market. Below mentioned is the list of few companies engaged in the Breast Biopsy System market.

The report also includes the profiles of key players in Breast Biopsy System market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

•   Biomed Diagnostics, Inc.
  
•   Bard Peripheral Vascular Inc.
  
•   F. Hoffmann-La Roche Ltd.
  
•   Hologic Inc.
  
•   Leica Biosystems
  
•   OncoCyte Corporation
  
•   Laboratory Corporation of America Holdings (Labcorp)
  
•   Becton, Dickson and Company
  
•   Danaher Corporation
  
•   Medtronic plc
  

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.

Breast Biopsy System Market Report Scope